Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial
Noora Neittaanmäki(University of Helsinki), Erna Snellman(Tampere University Hospital), M Grönroos(Päijät-Hämeen Keskussairaala), Toni Karppinen(Päijät-Hämeen Keskussairaala), Taneli Tani(Päijät-Hämeen Keskussairaala)
Cited by 18
Related Papers
A clinical benchmark of public self-supervised pathology foundation models
|Nature Communications|2025|93
Daylight photodynamic therapy for actinic keratoses: a randomized double‐blinded nonsponsored prospective study comparing 5‐aminolaevulinic acid nanoemulsion ( <scp>BF</scp> ‐200) with methyl‐5‐aminolaevulinate
|British Journal of Dermatology|2014|76
Attitudes Toward Artificial Intelligence Within Dermatopathology: An International Online Survey
|Frontiers in Medicine|2020|51
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
|Nature Medicine|2025|50
Detecting field cancerization using a hyperspectral imaging system
|Lasers in Surgery and Medicine|2013|43